Wenn Sie alle Cookies akzeptieren, profitieren Sie vom bestmöglichen Benutzererlebnis auf unserer Website, einschließlich personalisierter Inhalte und Social-Media-Funktionen. Wenn Sie nur notwendige Cookies akzeptieren, surfen Sie auf unserer Website mit minimaler Cookie-Nutzung. Es kann jedoch sein, dass Ihnen Teile der Website nicht korrekt angezeigt werden. Mehr zu diesem Thema finden Sie in unserer Datenschutzrichtlinie.
For the past two years, many Life Sciences companies have put preparation for the EMA’s ISO IDMP on hold. So how can these companies now catch up to the changing compliance demands? In a recent article for MedTech Intelligence, Amplexor’s Siniša Belina explores the answer to this question.
About the Author
Siniša Belina is a Senior Life Sciences Consultant within the Product Management team. He applies his detailed knowledge of pharmaceutical processes and documentation to the areas of business process analysis, optimization of software solutions and demonstration of their capabilities. He started his professional career at Pliva (now the TEVA Group), where in addition to his responsibilities in manufacturing, he engaged in a successful EDMS implementation project. He later joined KRKA’s Regulatory Affairs Department, and finally moved to Amplexor in 2008. Siniša received his Bachelor of Science degree in Pharmacy from Zagreb University.
